Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan.

BackgroundHepatitis B virus carriers who receive systemic cancer chemotherapy have been found to be at a higher risk of hepatitis B virus reactivation. However, lack of standard prophylaxis protoco...